Skip to main content
Clinical Trials/NCT02710097
NCT02710097Active, not recruitingPhase 1

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II

Yale University1 site in 1 country40 target enrollmentStarted: March 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
40
Locations
1
Primary Endpoint
Road Tracking Error

Study Overview

Brief Summary

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

Detailed Description

To study the effects of oral ethanol (target BAC of ~0.04g/dl; equivalent to consuming approximately 2 drinks over 1 hour) and vaporized cannabis (~450 mg cannabis plant material at a THC concentration of ~1.7%; roughly equivalent to smoking approximately 1/4 of a marijuana cigarette, or "joint") on driving.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
21 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Males or females 21 to 55 years of age (extremes included).
  • Occasional current cannabis users.
  • Experience with drinking 2 or more standard drinks of alcohol at least once in lifetime.
  • Able to provide informed consent.

Exclusion Criteria

  • Cannabis naïve.
  • Alcohol naïve.
  • Positive pregnancy screen
  • Hearing deficits.

Arms & Interventions

Active THC and Placebo Ethanol

Experimental

Intervention: Active inhaled cannabis (Drug)

Active THC and Placebo Ethanol

Experimental

Intervention: Placebo (Drug)

Active THC and Active Ethanol

Experimental

Intervention: Active inhaled cannabis (Drug)

Active THC and Active Ethanol

Experimental

Intervention: Active Oral Ethanol (Drug)

Placebo THC and Active Ethanol

Experimental

Intervention: Active Oral Ethanol (Drug)

Placebo THC and Active Ethanol

Experimental

Intervention: Placebo (Drug)

Placebo THC and Placebo Ethanol

Placebo Comparator

Intervention: Placebo (Drug)

Outcomes

Primary Outcomes

Road Tracking Error

Time Frame: baseline, +20, +50, +120, +180 mins after start of alcohol administration

Secondary Outcomes

  • Number of Drinks Scale(baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration)
  • Cognitive Test Battery(+40 mins after start of alcohol administration)
  • Willingness to Drive Scale(baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration)
  • Biphasic Alcohol Effects Scale (BAES)(baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration)
  • Visual Analog Scale (VAS)(baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration)
  • Number of Joints Scale(baseline, +20, +50, +120, +180, +240 mins after start of alcohol administration)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Deepak C. D'Souza

Professor of Psychiatry

Yale University

Study Sites (1)

Loading locations...

Similar Trials

Ethanol and Cannabinoid Effects on... | Clinical Trial